(Total Views: 412)
Posted On: 12/28/2019 2:40:40 PM
Post# of 153889
That's the million dollar question...
I think a slight retrace then steady rise, or another gap-up is likely. The fact that CYDY has been de-risked and there are so many catalysts coming is going to bring in new folks. Awareness was always a problem but now we're seeing that change and it can only get better.
Someone posted here last week that they overheard two ER docs talking about Leronlimab. We're going to hit so many radars that this recent rise in value, IMO, is only the beginning.
Personally, I'm hoping for another PR next week. That could make last week's action pale in comparison. No way do I want to take a chunk off the table sub-dollar if that happens.
I think a slight retrace then steady rise, or another gap-up is likely. The fact that CYDY has been de-risked and there are so many catalysts coming is going to bring in new folks. Awareness was always a problem but now we're seeing that change and it can only get better.
Someone posted here last week that they overheard two ER docs talking about Leronlimab. We're going to hit so many radars that this recent rise in value, IMO, is only the beginning.
Personally, I'm hoping for another PR next week. That could make last week's action pale in comparison. No way do I want to take a chunk off the table sub-dollar if that happens.
(5)
(0)
